Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk
- 18 October 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 154 (4) , 670-678
Abstract
Genome‐wide association studies (GWAS) have identified two dozen genetic variants that are associated with the risk of pancreatic ductal adenocarcinoma (PDAC), a deadly malignancy. However, a majority of these variants are located in noncoding regions of the genome, which limits the translation of GWAS findings into clinical applications. The regulome‐wide association study (RWAS) is a recently developed method for identifying TF binding‐induced accessibility regions for diseases. However, their potential connection to PDAC has yet to be fully explored. We evaluated the associations between genetically predicted levels of chromatin accessibility and risk of PDAC by using pan‐cancer chromatin accessibility genetic prediction models. Our analysis included 8275 cases and 6723 controls from the PanScan (I, II, and III) and PanC4 consortia. To further refine our results, we also integrated genes associated to allele‐specific accessibility quantitative trait loci (as‐aQTL) and TF motifs located in the as‐aQTL. We found that 50 chromatin accessibility features were associated with PDAC risk at a false discovery rate (FDR) of less than 0.05. A total of 28 RWAS peaks were identified as conditionally significant. By integrating the results from as‐aQTL, motif analysis, and RWAS, we identified candidate causal regulatory elements for two potential chromatin accessibility regions (THCA_89956 and ESCA_89167) that are associated with PDAC risk. Our study identified chromatin accessibility features in noncoding genomic regions that are associated with PDAC risk. We also predicted the associated genes and disrupt motifs. Our findings provide new insights into the regulatory mechanisms of noncoding regions for pancreatic tumorigenesis.Keywords
Funding Information
- National Human Genome Research Institute (U54HG013243)
- National Institute of General Medical Sciences (9 SC1 GM135050‐05)
- National Institute on Minority Health and Health Disparities (G0812D05)
This publication has 40 references indexed in Scilit:
- HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and diseaseNucleic Acids Research, 2015
- Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancerNature Genetics, 2015
- The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humansScience, 2015
- Genome-wide association study identifies multiple susceptibility loci for pancreatic cancerNature Genetics, 2014
- Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting PrognosisPLOS ONE, 2014
- Annotation of functional variation in personal genomes using RegulomeDBGenome Research, 2012
- A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33Nature Genetics, 2010
- Up-Regulation of Krüppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1β Signaling and Hypoxia-Inducible Factor-1αMolecular Cancer Research, 2009
- Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancerNature Genetics, 2009
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association StudiesPLOS Genetics, 2009